so I wonder if acadia are expecting revenue from europe under the market access program in 2q25, does that mean the first milestone payment of USD$35m will be triggered? I would think yes but perhaps something for neu to clarify.
- Forums
- ASX - By Stock
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.98%
!
$13.18

so I wonder if acadia are expecting revenue from europe under...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.18 |
Change
-0.130(0.98%) |
Mkt cap ! $1.650B |
Open | High | Low | Value | Volume |
$13.50 | $13.58 | $12.96 | $1.066M | 80.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20 | $13.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.19 | 235 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 375 | 13.170 |
3 | 459 | 13.160 |
2 | 300 | 13.150 |
4 | 1184 | 13.140 |
4 | 701 | 13.130 |
Price($) | Vol. | No. |
---|---|---|
13.220 | 197 | 3 |
13.230 | 527 | 5 |
13.240 | 438 | 4 |
13.250 | 1300 | 7 |
13.260 | 389 | 3 |
Last trade - 10.19am 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online